Genelex Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Genelex General Information

Description

Provider of drug sensitivity test services based in Seattle Washington. The company offers DNA drug sensitivity tests and a personalized prescribing platform for doctors to avoid drug side effects and reactions.

Contact Information

Website
www.genelex.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3101 Western Avenue
  • Suite 100
  • Seattle, WA 98121
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Acquirer
Invitae
Vertical(s)
Life Sciences
Corporate Office
  • 3101 Western Avenue
  • Suite 100
  • Seattle, WA 98121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genelex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genelex‘s full profile, request access.

Request a free trial

Genelex Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Genelex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220293235-A1 Systems and methods for quantification and presentation of medical risk arising from unknown factors Pending 03-Feb-2013
US-5106477-A Electrophoresis buffer circulation apparatus Inactive 06-Nov-1990
JP-H03130100-A Dna probe for vntr gene locus Pending 10-Feb-1989
EP-0382261-A2 Dna probes to vntr loci Inactive 10-Feb-1989
EP-0382261-A3 Dna probes to vntr loci Inactive 10-Feb-1989 C12Q1/6876
To view Genelex’s complete patent history, request access »

Genelex Acquisitions (1)

Genelex’s most recent deal was a Merger/Acquisition with Mental Health Connections. The deal was made on 08-Jun-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mental Health Connections 08-Jun-2010 Merger/Acquisition Other Healthcare Technology Systems
To view Genelex’s complete acquisitions history, request access »

Genelex FAQs

  • When was Genelex founded?

    Genelex was founded in 1987.

  • Where is Genelex headquartered?

    Genelex is headquartered in Seattle, WA.

  • What industry is Genelex in?

    Genelex’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Genelex a private or public company?

    Genelex is a Private company.

  • What is the current valuation of Genelex?

    The current valuation of Genelex is .

  • What is Genelex’s current revenue?

    The current revenue for Genelex is .

  • When was Genelex acquired?

    Genelex was acquired on 01-Apr-2020.

  • Who acquired Genelex?

    Genelex was acquired by Invitae.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »